Skip to main content

Table 1 Characteristics of HF according to gender

From: Clinical characteristics and in-hospital outcome of heart failure in women: a single center registry from Egyptian cardiac care unit

 Male, n = 178Female, n = 118P value
HFrEF113 (63.5%)73 (61.9%)0.579
Age59.9 ± 965.3 ± 110.0001
BMI29.84 ± 3.231.63 ± 40.01
Obesity81 (54.5%)80 (67.8%)0.000
DM74 (41.6%)45(38.1%)0.628
HTN109 (61.2%)67(56.8%)0.470
Dyslipidemia59 (33.1%)47(39.8%)0.266
Smoking120 (67%)2 (1.7%)0.000
Previous MI52 (29.6%)19 (16.1%)0.019
Previous PCI34 (19.1%)12 (10.2%)0.043
Prior CABG18 (10.1%)8 (6.78%)0.226
Valve surgery8 (4.5%)6 (5.1%)0.339
Addiction13 (7.3%)0 (0%)0.001
STEMI22 (12.4%)16 (14%)0.329
UA/NSTEMI16 (9%)21 (8.5%)0.878
Cardiogenic shock39 (22%)25 (21.2%)0.351
CHB3 (1.7%)1 (0.8%)0.296
AF/Flutter16 (8.9%)25 (21.2%)0.041
IE1 (0.6%)1 (0.8%)0.916
PE1 (0.6%)3 (2.5%)0.148
Aortic dissection1 (0.6%)3 (2.5%)0.148
Cardiomyopathies18 (10.1%)23 (19.5%)0.011
Chest pain (CP)35 (19.7%)25 (21.2%)0.199
Orthopnea118 (66%)80 (67.8%)0.195
PND40 (22.5%)16 (13.6%)0.040
Palpitations18 (10.1%)14 (11.9%)0.191
Syncope10 (5.62%)1 (0.85%)0.024
Cough55 (30.9%)38 (32.2%)0.704
Edema63 (35.4%)38 (32.2%)0.847
Pacemaker5 (2.8%)2 (1.7%)0.320
ICD0 (0%)1 (0.85%)0.163
Killip class   
 I33 (18.5%)11 (5.9%)0.023
 II8 (4.5%)6 (5.1%)0.211
 III32 (18%)27(22.8%)0.119
 IV102 (57%)71 (60.2%)0.176
Pricardiocentesis3 (1.7%)1 (0.85%)0.541
Thazides22 (12.4%)8 (6.8%)0.119
Loop diuretics109 (61%)68(57.6%)0.535
Nitrates103 (58%)67 (56.8%)0.853
Warfarin63 (35.4%)31 (26.3%)0.099
Clopedogril75 (42.1%)58 (49.2%)0.235
Aldesterone antagonist88 (49.4%)50 (42.4%)0.233
Digixon67 (37.6%)32 (27.1%)0.060
Duration of stay8.71 ± 77.06 ± 50.020
Mortality19 (10.7%)13(11.1%)0.740
HFpEF65 (36.5%)45(38.1%)0.524
Sepsis1 (0.6%)3(2.5%)0.254
Pneumonia5 (2.81%)6 (5.1%)0.204
AKI23 (13%)12 (10.2%)0.336
CKD/ESRD7 (4%)3 (2.5%)0.291
Resp. failure0(0%)4(3.4%)0.016
liver failure1(0.6%)9(7.6%)0.000
Tamponade1 (0.6%)3 (2.5%)0.254
GIT bleeding1 (0.6%)3 (2.5%)0.148
CCI167 (93%)112 (94%)0.692
Previous MI54 (30.3%)17 (14.4%)0.003
Previous CHF85 (47.8%)42 (35.6%)0.054
PVD5 (2.8%)2 (1.7%)0.296
CVA/TIA9 (5.1%)10 (8.5%)0.167
Hemiplegia1 (0.6%)2 (1.7%)0.220
COPD15 (8.4%)10 (8.5%)0.351
VHD14 (7.8%)18(15.2%)0.020
Peptic ulcer0 (0%)1(0.85%)0.163
Cancer0 (0%)1 (0.85%)0.163
Depression1 (0.6%)2 (1.7%)0.220
Dementia6 (3.4%)3 (2.5%)0.328
Metastasis1 (0.6%)3 (2.5%)0.148
Endotracheal intubation27 (15.2%)15 (13%)0.553
HIV1 (0.6%)1 (0.85%)0.336
Cellulitis1 (0.6%)9 (7.6%)0.000
PCI20 (11.2%)7 (6%)0.021
CRT3 (1.68%)2 (1.69%)0.329
Mechanical ventilation28 (15.7%)15 (22%)0.471
CVP121 (68%)71 (60%)0.168
CA4 (2.25%)5 (4.24%)0.329
DC shock8 (4.5%)1 (0.85%)0.044
Coma1 (0.6%)0 (0%)0.437
Fever1 (0.6%)1 (0.85%)
Hemoptysis0 (0.6%)1 (0.85%)
Lanoxin toxicisty0 (0%)1 (0.85%)
Mechanical ventilation28 (15.7%)15(21.7%)0.471
Amiodarone17 (9.6%)7 (14.4%)0.200
UFH62(34.8%)34(28.8%)0.279
LMWH100(56.2%)79 (67%)0.064
Lytic therapy45 (25.3%)32(27.1%)0.724
ACEI/ARBS112(62.9%)78(66.1%)0.741
Warfarin22 (12.4%)22(18.6%)0.137
Beta-blockers61 (34.3%)45 (38%)0.794
Survivors159 (89%)105 (88%)0.750
  1. BMI body mass index, DM diabetes mellitus, HTN hypertension, STEMI ST segment elevation myocardial infarction, UA unstable angina, IE infective endocarditis, PE pulmonary embolism, PND paroxysmal nocturnal dyspnea, CHB complete heart block, Af atrial flutter, AF atrial fibrillation, CCI Charlson comorbidity index, PCI percutaneous coronary intervention, CA coronary angiography, CVA cerebrovascular accident